Subscribe
Global Health News
  • Gates Foundation Gives Millions for Coverage of World Health

    Source: New York Times
    By DONALD G. McNEIL JR.
    Published: December 8, 2008
    A major limitation on journalists covering global health is the cost: getting to a story can mean airfare to Africa or Asia, hotels, Jeep rentals, satellite phones, translators, sometimes even armed guards.
    Meanwhile, many news organizations are cutting back.
    Now the Bill and Melinda Gates Foundation, which [...]


  • Source: Wall Street Journal
    9/12/08
    By JEANNE WHALEN
    LONDON — The fight against malaria, one of the world’s biggest killers, has just gotten a booster.
    An experimental vaccine has shown promise in two studies in African children, who account for the majority of the more than one million victims that malaria claims every year. Published online Monday in the [...]

  • Govt boosts aid to help 'failed state' Zimbabwe: PM

    Dec 4, 2008
    LONDON (AFP) — The govenment announced 10 million pounds of emergency aid to help tackle Zimbabwe’s cholera crisis Thursday, while denouncing President Robert Mugabe as leader of a “failed state.”
    The pledge came as Zimbabwe pleaded for international help after declaring the epidemic that has killed over 560 people a national emergency, and admitted [...]

  • Measles Deaths Worldwide Fall by 74 Percent

    Source: VOA News
    By Jessica Berman
    Washington
    04 December 2008
    Health officials say aggressive efforts to vaccinate young children against measles have resulted in a 74 percent global decline in the number of deaths due to the illness. Experts say the biggest decline, 90 percent, occurred in the Eastern Mediterranean region.
    Global health officials say that from 2000 through 2007, [...]

  • GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program

    Source: MarketWatch
    Last update: 7:00 p.m. EST Dec. 4, 2008
    LONDON and PHILADELPHIA, Dec 04, 2008 /PRNewswire-FirstCall via COMTEX/ — - GSK CEO marks 10th anniversary of drive to eliminate lymphatic filariasis (LF) with donation of one-billionth albendazole tablet and grant to The Carter Center
    In a meeting today with former U.S. President and founder of The Carter [...]

  • AIDS conference urges West to keep funding pledges

    Source: AFP
    3 December 2008
    DAKAR (AFP) — AIDS activists urged Western donors Wednesday to keep their pledges to a fund to fight the disease amid fears that the global financial crisis could hurt the campaign.
    “Already we are missing billions of euros in funding and the current financial crisis means that it could become more difficult to [...]

  • Essential medicines out of reach for most people

    Source: WHO Press Release
    Lack of medicines in public sector forcing patients to pay high prices, finds new study
    Low availability, high prices keep essential medicines out of reach: WHO study
    1 December 2008 | GENEVA — An alarming lack of availability of essential medicines in the public sector drives patients to pay higher prices in the private [...]

  • New HIV Cases Could Be Reduced By 95% With Universal Voluntary Testing And Immediate Treatment, Mathematical Model Shows

    ScienceDaily (Dec. 1, 2008) — Universal and annual voluntary testing followed by immediate antiretroviral therapy treatment (irrespective of clinical stage or CD4 count) can reduce new HIV cases by 95% within 10 years, according to new findings based on a mathematical model developed by a group of HIV specialists in WHO.
    Authors of the study also [...]

  • UN warns against cuts to AIDS prevention programmes

    (Adds remarks on new class of drugs, new paragraphs 9-14)
    By Stephanie Nebehay
    GENEVA, Nov 28 (Reuters) - HIV infections could surge if countries pinched by the global financial crisis cut AIDS prevention programmes, a United Nations agency said on Friday.
    Paul De Lay, a senior official at UNAIDS, said that economic turmoil was a threat to development [...]

  • Experimental TB Drug Explodes Bacteria From The Inside Out

    Source: ScienceDaily
    Nov. 28, 2008
    An international team of biochemists has discovered how an experimental drug unleashes its destructive force inside the bacteria that cause tuberculosis (TB). The finding could help scientists develop ways to treat dormant TB infections, and suggests a strategy for drug development against other bacteria as well.
    A report describing the research, led by [...]

  • World Bank presses aid to developing world to ease crisis

    29 November 2008
    WASHINGTON (AFP) — The World Bank Saturday urged industrialized nations to maintain aid flows to developing nations to offset an expected decline in private capital flows to emerging markets due to the credit crisis.
    “Over the past year, many developing countries have already had to cope with high food and fuel prices, and are [...]

  • UK funds for S Africa Aids fight

    By Susan Watts
    BBC Newsnight
    Aids hopes of SA’s new health minister
    The UK is to give South Africa’s new Health Minister Barbara Hogan £15m to help combat Aids in the country.
    Ms Hogan was appointed health minister in September to help shake up a health service in crisis.
    South Africa has one of the most severe HIV/Aids epidemics in [...]

  • UNAIDS Urges More Transparency on HIV Reporting

    Source: Voice of America (VOA)
    By Lisa Bryant
    Paris
    28 November 2008
    A new report by UNAIDS urges countries to adopt flexible policies that reflect how and why the latest HIV infections are transmitted. The report coincides with the 20th anniversary of World AIDS Day. For VOA, Lisa Bryant has more from Paris.
    HIV infected patients resting in a hospital [...]

  • Drugmakers abuse patents to block generics, says EU, EFPIA objects

    Source: PharmaTimes
    28 November 2008
    By Lynne Taylor
    Tactics used by pharmaceutical manufacturers to delay or block the entry onto the market of cheaper generics mean that European Union member states spent around 3 billion euros more during 2000-2007 than they would have if the generics had been available without delay, according to the preliminary findings of an [...]

  • Model Predicts Halt to Africa's AIDS Epidemic

    By David Brown
    Washington Post Staff Writer
    Wednesday, November 26, 2008; Page A04
    A strategy of testing adults every year for HIV and immediately treating every person found to be infected could virtually end the AIDS epidemic in Africa in about a decade, new research suggests.
    While nobody is seriously espousing that approach, the “thought experiment” outlined this week [...]


What is HIV | AIDS?

What is AIDS?

AIDS is an acronym that stands for Acquired Immunodeficiency Syndrome.

  • Acquired means that the virus is contracted from an external source. AIDS is not contagious in the same way that the flu is. It has to be contracted by direct exposure to infected bodily fluids. Sexual intercourse, the sharing of needles, and mother to child transmission during birth are the most common means of contraction.
  • Immunodeficiency means that AIDS attacks the immune system. It makes the human body incapable of fighting other diseases, and the thousands of germs that we all encounter in our every-day lives.
  • Syndrome means that AIDS presents itself not as a single disease, but rather as a whole set of diseases that attack the person living with AIDS as the immune system weakens.

HIV stands for Human Immunodeficiency Virus. The difference between HIV and AIDS is a subtle one. When a person originally contracts the disease, they are said to be HIV positive. The person is said to have AIDS when the HIV infection has destroyed enough of the immune system that it is no longer able to protect the body from opportunistic infections.

The Numbers

  • Almost 40 million people worldwide are living with HIV/AIDS.
  • There were nearly five million new infections in 2000 - that?s a new infection about every seven seconds.
  • Since the beginning of the epidemic, thirty million people have died.
  • In some sub-Saharan countries like Zimbabwe, Botswana, and Swaziland, more than 1/3 of the adult population is living with HIV.
  • In sub-Saharan Afirca, women account for 57% of all new HIV cases.
  • Worldwide, youth between 15 and 24 account for about half of new HIV cases.

HIV/AIDS in the Developing World

90% of people living with HIV are in the developing world.
In sub-Saharan Africa alone, more than 28 million people are living with HIV. Most new infections also occur in the developing world.

In the developing world, governments do not have the resources to fight the epidemic. AIDS prevention education is limited by monetary constraints, and fragmented education systems. Testing for HIV and providing care for people living with HIV is difficult because of high costs and poorly developed health infrastructure.

The crushing load of international debt that the developing world bears, as well as structural adjustment programs which force them to reduce government spending, often prevent developing world countries from investing more resources into combating HIV/AIDS. The immigration of health care workers to rich countries like canada makes the situation even worse.

Finally, for the many people in the developing world who are struggling to survive from one day to the next, AIDS seems like a remote danger. These same people point out that getting tested makes little sense since regardless of their status, they will not be able to afford treatment.

The Effects of HIV/AIDS

Besides the grief that sickness and loss of a loved one inevitably causes, HIV/AIDS often kills parents and providers. When a family loses a parent or provider, the family has to find new ways to survive. This often includes taking children out of school to work, or to care for their younger siblings. It might also force the remaining parent or older children into sex work - where there is a increased risk of contracting HIV/AIDS.

Because of the way that HIV/AIDS is transmitted, it often kills both parents of a family. This can mean that the oldest children in a family are forced to act as parent-providers. Other times, members of the extended family take children in - sometimes as many as twelve or more from the various parts of the extended family. But the disease is killing members of extended families too. Family networks can only stretch so far before they break. Caring for the thirty-four million AIDS orphans worldwide is one of the most pressing consequences of the global HIV/AIDS pandemic.

HIV/AIDS makes it difficult for communities to function and countries to develop by killing off people in their most productive years, just when society needs them most. Children cannot learn when their teachers and bus drivers are dying. People cannot get well when doctors, nurses, and public health workers are dying. Governments cannot function when administrators, taxmen, and politicians are dying.

Why are most Still Dying?

Today in the developed world, HIV is a chronic, rather than deadly disease. Antiretroviral drugs (ARVs) cannot cure HIV, but they can slow its progression. More importantly, they allow people living with HIV to live normal, healthy, and happy lives. Unfortunately, only approximately seven percent of the people in the developing world that need treatment actually receive it. This is called the access gap.

Companies that develop new medicines have the right to patent them. Patentees (called brand-name manufacturers) are given exclusive production and distribution rights over the patented drug for a given period of time, normally twenty years. During this period, the patent holder has the right to sell the patented medicine at whatever price it wishes to. As a result, patented medicines are very expensive. When the patent expires, other companies (called generic manufacturers) are allowed to sell and produce chemically identical versions of the medicine in question. The resulting competition drives the cost of medicine down.

In theory, the patent system is fantastic. Companies that spend lots of time and money on the development of new medicines can pay off the cost of the development of the medicine during the patent period. Unfortunately, the system is based on the deadly assumption that people who need the patented medicines, or their health insurance, can afford them. Unfortunately, this is not the case in the developing world, where the resources to pay for treatment, which can cost hundreds of dollars a day, are simply not available.

The access gap must be closed. Importantly, the World Trade Organization ? which has the job of standardizing intilectual property law ? has recently agreed that public health must be the primary concern of governments and that intilectual property rights do not trump the right to health. The fight for access continues. There are still millions who urgently need treatment and are not receiving it.

UNAIDS has taken the lead in the fight for treatment access with the 3 by 5 campaign. The campaign aimed to provide treatment to 3 million in the developing world by 2005. Unfortunately, although much progress has been made, this goal was not met.

What is Required to Close the Gap?

  • More political will to put public health above private profits.
  • Increased price-reducing competition from generic pharmaceutical manufacturers.
  • Trade rules that allow developing countries to make the health of their people a priority.

What Can We Do About it?

After learning a little about the global HIV/AIDS pandemic, it is easy to feel helpless - to feel that there is nothing that you could do to help, but this is not the case.

One of the most important things that you can do is help raise awareness in the developed world about the extent and gravity of the global HIV/AIDS pandemic. Along with this first step, be sure to educate yourself too.

The next thing you can do is make sure that your elected representatives know that you think fighting the pandemic should be a priority. At the same time, you can encourage them to support dropping third world debt, to increase international development assistance, to increase contributions to the Global Fund to fight AIDS, Malaria, and Tuberculosis, and to not support national or international legislation that would put intellectual property rights over the right to health.

Finally, if you are interested in becoming more involved in international AIDS activism, you can join your local SAGA chapter.

Leave a Reply

About MGAC
McGill Global AIDS Coalition is an HIV/AIDS advocacy group dedicated to the eradication of HIV/AIDS and to the realization, worldwide, of the right to health. We are committed to helping to create an effective student advocacy network in Canada and to educating the McGill and Montreal community on global health issues
MGAC Outreach Subscription
Google Groups
Subscribe to MGAC Outreach (Learn more)
Email:
Visit this group